Weight loss and heart failure: A nationwide study of gastric bypass surgery versus intensive lifestyle treatment

Circulation

Volumn 135, Issue 17, 2017, Pages 1577-1585

  Sundström, Johan ^a   Bruze, Gustaf ^b   Ottosson, Johan ^c   Marcus, Claude ^b   Näslund, Ingmar ^c   Neovius, Martin ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Örebro University   (Sweden)

Author keywords

Bariatric surgery; Diet, reducing; Gastric bypass; Heart failure; Weight loss

Indexed keywords

ADULT; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; BODY WEIGHT; CARDIAC PATIENT; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; GASTRIC BYPASS SURGERY; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ICD-10; INCIDENCE; LIFESTYLE MODIFICATION; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; WEIGHT LOSS PROGRAM; WEIGHT REDUCTION; ADVERSE EFFECTS; LAPAROSCOPY; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SWEDEN; TIME FACTOR; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; FEMALE; GASTRIC BYPASS; HEART FAILURE; HUMANS; INCIDENCE; LAPAROSCOPY; MALE; OBESITY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SWEDEN; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 85018280765     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.025629     Document Type: Article

References (33)

1. NCD Risk Factor Collaboration (NCD-RisC), Di Cesare M, Bentham J, Stevens GA, Zhou B, Danaei G, Lu Y, Bixby H, Cowan MJ, Riley LM, Hajifathalian K, Fortunato L, Taddei C, Bennett JE, Ikeda N, Khang YH, Kyobutungi C, Laxmaiah A, Li Y, Lin HH, Miranda JJ, Mostafa A, Turley ML, Paciorek CJ, Gunter M, Ezzati M. Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387:1377-1396.
2. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CS, Sato N, Shah AN, Gheorghiade M. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63:1123-1133. doi: 10.1016/j.jacc.2013.11.053.
3. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313. doi: 10.1056/NEJMoa020245.
4. Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, Vatten LJ. Body mass index, abdominal fatness, and heart failure incidence and mortality: A systematic review and dose-response meta-analysis of prospective studies. Circulation. 2016;133:639-649. doi: 10.1161/CIRCULATIONAHA.115.016801.
5. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97:1784-1789.
6. Fall T, Hägg S, Mägi R, Ploner A, Fischer K, Horikoshi M, Sarin AP, Thorleifsson G, Ladenvall C, Kals M, Kuningas M, Draisma HH, Ried JS, van Zuydam NR, Huikari V, Mangino M, Sonestedt E, Benyamin B, Nelson CP, Rivera NV, Kristiansson K, Shen HY, Havulinna AS, Dehghan A, Donnelly LA, Kaakinen M, Nuotio ML, Robertson N, de Bruijn RF, Ikram MA, Amin N, Balmforth AJ, Braund PS, Doney AS, Döring A, Elliott P, Esko T, Franco OH, Gretarsdottir S, Hartikainen AL, Heikkilä K, Herzig KH, Holm H, Hottenga JJ, Hyppönen E, Illig T, Isaacs A, Isomaa B, Karssen LC, Kettunen J, Koenig W, Kuulasmaa K, Laatikainen T, Laitinen J, Lindgren C, Lyssenko V, Läärä E, Rayner NW, Männistö S, Pouta A, Rathmann W, Rivadeneira F, Ruokonen A, Savolainen MJ, Sijbrands EJ, Small KS, Smit JH, Steinthorsdottir V, Syvänen AC, Taanila A, Tobin MD, Uitterlinden AG, Willems SM, Willemsen G, Witteman J, Perola M, Evans A, Ferrières J, Virtamo J, Kee F, Tregouet DA, Arveiler D, Amouyel P, Ferrario MM, Brambilla P, Hall AS, Heath AC, Madden PA, Martin NG, Montgomery GW, Whitfield JB, Jula A, Knekt P, Oostra B, van Duijn CM, Penninx BW, Smith GD, Kaprio J, Samani NJ, Gieger C, Peters A, Wichmann HE, Boomsma DI, de Geus EJ, Tuomi T, Power C, Hammond CJ, Spector TD, Lind L, Orho-Melander M, Palmer CN, Morris AD, Groop L, Järvelin MR, Salomaa V, Vartiainen E, Hofman A, Ripatti S, Metspalu A, Thorsteinsdottir U, Stefansson K, Pedersen NL, McCarthy MI, Ingelsson E, Prokopenko I; European Network for Genetic and Genomic Epidemiology (ENGAGE) Consortium. The role of adiposity in cardiometabolic traits: A mendelian randomization analysis. PLoS Med. 2013;10:e1001474. doi: 10.1371/journal.pmed.1001474.
7. Aggarwal R, Harling L, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H. The effects of bariatric surgery on cardiac structure and function: A systematic review of cardiac imaging outcomes. Obes Surg. 2016;26:1030-1040. doi: 10.1007/s11695-015-1866-5.
8. Hedenbro JL, Näslund E, Boman L, Lundegardh G, Bylund A, Ekelund M, Laurenius A, Möller P, Olbers T, Sundbom M, Ottosson J, Näslund I. Formation of the Scandinavian Obesity Surgery Registry, SOReg. Obes Surg. 2015;25:1893-1900. doi: 10.1007/s11695-015-1619-5.
9. Johansson K, Sundström J, Marcus C, Hemmingsson E, Neovius M. Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study. Int J Obes (Lond). 2014;38:279-284. doi: 10.1038/ijo.2013.83.
10. Hemmingsson E, Johansson K, Eriksson J, Sundström J, Neovius M, Marcus C. Weight loss and dropout during a commercial weight-loss program including a very-low-calorie diet, a low-calorie diet, or restricted normal food: observational cohort study. Am J Clin Nutr. 2012;96:953-961. doi: 10.3945/ajcn.112.038265.
11. Ingelsson E, Arnlöv J, Sundström J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail. 2005;7:787-791. doi: 10.1016/j.ejheart.2004.12.007.
12. Blackwell M, Iacus S, King G, Porro G. CEM: coarsened exact matching in Stata. Stata J. 2009;9:524-546.
13. Ludvigsson JF, Almqvist C, Bonamy AK, Ljung R, Michaëlsson K, Neovius M, Stephansson O, Ye W. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31:125-136. doi: 10.1007/s10654-016-0117-y.
14. Lim CP, Fisher OM, Falkenback D, Boyd D, Hayward CS, Keogh A, Samaras K, MacDonald P, Lord RV. Bariatric surgery provides a "bridge to transplant" for morbidly obese patients with advanced heart failure and may obviate the need for transplantation. Obes Surg. 2016;26:486-493. doi: 10.1007/s11695-015-1789-1.
15. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: A meta-analysis. Am Heart J. 2008;156:13-22. doi: 10.1016/j.ahj.2008.02.014.
16. Sharma A, Lavie CJ, Borer JS, Vallakati A, Goel S, Lopez-Jimenez F, Arbab-Zadeh A, Mukherjee D, Lazar JM. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015;115:1428-1434. doi: 10.1016/j.amjcard. 2015.02.024.
17. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, Ahlin S, Anveden A, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, Lönroth H, Narbro K, Näslund I, Olbers T, Svensson PA, Carlsson LM. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56-65. doi: 10.1001/jama.2011.1914.
18. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693. doi: 10.1056/NEJMoa035622.
19. Ingelsson E, Björklund-Bodegard K, Lind L, Arnlöv J, Sundström J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 2006;295:2859-2866. doi: 10.1001/jama.295.24.2859.
20. Ingelsson E, Sundström J, Arnlöv J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA. 2005;294:334-341. doi: 10.1001/jama.294.3.334.
21. Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, Jacobson P, Lönroth H, Maglio C, Näslund I, Pirazzi C, Romeo S, Sjöholm K, Sjöström E, Wedel H, Svensson PA, Sjöström L. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695-704. doi: 10.1056/NEJMoa1112082.
22. Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A, Bouchard C, Carlsson B, Karason K, Lönroth H, Näslund I, Sjöström E, Taube M, Wedel H, Svensson PA, Sjöholm K, Carlsson LM. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297-2304. doi: 10.1001/jama.2014.5988.
23. Schauer PR, Bhatt DL, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med. 2014;371:682. doi: 10.1056/NEJMc1407393.
24. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-1585. doi: 10.1056/NEJMoa1200111.
25. Sundström J, Ingelsson E, Berglund L, Zethelius B, Lind L, Venge P, Arnlöv J. Cardiac troponin-I and risk of heart failure: A community-based cohort study. Eur Heart J. 2009;30:773-781. doi: 10.1093/eurheartj/ehp047.
26. Lyngbakken MN, Omland T, Nordstrand N, Norseth J, Hjelmesæth J, Hofsø D. Effect of weight loss on subclinical myocardial injury: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Prev Cardiol. 2016;23:874-880. doi: 10.1177/2047487315618796.
27. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions: potential for pharmacological interventions. Cardiovasc Res. 1997;33:243-257.
28. Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, Ono T, Hasegawa G, Naito M, Nakajima T, Kamijo Y, Gonzalez FJ, Aoyama T. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. J Biol Chem. 2000;275:22293-22299. doi: 10.1074/jbc.M000248200.
29. Young ME, Guthrie PH, Razeghi P, Leighton B, Abbasi S, Patil S, Youker KA, Taegtmeyer H. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes. 2002;51:2587-2595.
30. Lu MC, Tzang BS, Kuo WW, Wu FL, Chen YS, Tsai CH, Huang CY, Lee SD. More activated cardiac mitochondrial-dependent apoptotic pathway in obese Zucker rats. Obesity (Silver Spring). 2007;15:2634-2642. doi: 10.1038/oby.2007.315.
31. Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, Bielicki JK, Mertens A, Quarck R, Benhabilès N, Marguerie G, Mackness B, Mackness M, Ninio E, Herregods MC, Balligand JL, Holvoet P. Weight-loss-associated induction of peroxisome proliferatoractivated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice. Circulation. 2004;110:3259-3269. doi: 10.1161/01. CIR.0000147614.85888.7A.
32. Fitchett D, Zinman B, Wanner C, Lachin JM, Hantel S, Salsali A, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME® Trial Investigators. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial. Eur Heart J. 2016;37:1526-1534. doi: 10.1093/eurheartj/ehv728.
33. Ludwig DS, Ebbeling CB, Livingston EH. Surgical vs lifestyle treatment for type 2 diabetes. JAMA. 2012;308:981-982. doi: 10.1001/2012.jama.10156.